22nd International Vascular Biology Meeting

项目总结 自1980年创办以来，国际血管生物学会议(IVBM)一直是历史悠久的 影响深远的两年一度的活动。这次会议为全球社会提供了一个独特的机会 交流和讨论新的科学发现，规划创新和合作的未来科学 血管生物学方向。IVBM还培养了血管领域的下一代科学家 医药。IVBM 2022(2022年10月13日至17日在加利福尼亚州奥克兰举行)将涵盖血管生物学的广泛领域， 确定新兴研究领域的优先顺序。血管系统影响每个器官系统的发育、衰老和 这是一种疾病，对再生过程至关重要。血管壁调节多种生理功能， 包括血管紧张性、白细胞运输、先天和获得性免疫、通透性、干细胞 分化、再生和新的血液生成。这些功能中的任何一个的异常都会导致疾病。 除了动脉粥样硬化和高血压等传统的血管壁病理外，血管系统还起到了 癌症、神经疾病、糖尿病、血液和免疫疾病、衰老和传染性疾病 进程，最近的新冠肺炎。越来越多的证据表明，许多新冠肺炎症状是由于 攻击血管系统的病毒。血管生物学的进步导致了许多新的 影响广泛的治疗和预防策略，包括那些减缓肿瘤生长和恢复的治疗和预防策略 幻象。IVBM 2022将提供一个及时的论坛，交流快速扩张的 血管生物学，促进跨学科合作和经验丰富的 研究人员和受训人员，并促进对健康和疾病中不同血管床的认识。我们的目标 是点燃学术界和工业界之间的新研究领域，从基础研究到翻译研究和 临床医学，以改善人类健康为最终目标。2022年IVBM是由朝鲜组织的 美国血管生物学组织(NAVBO)，一个在促进 实习生和初级教员。相当数量的口头报告被保留给初级科学家以促进 他们的职业发展。NAVBO致力于血管生物学内外的多样性和公平性 社区；IVBM的组织者和演讲者包括女性、初级教职员工、代表不足的群体以及 来自世界各地的科学家。我们选择了加利福尼亚州奥克兰这座多元化的城市作为会议地点。我们的 该计划促进了与不同血管床(脑、心、肺、 肾脏、肝脏和眼睛)和不同的学科(细胞生物学、遗传学、成像、生物工程、数学、 物理学、系统生物学、转化研究和药物发现)。通过促进这种互动，我们将 产生关于发育和疾病过程的新的基本知识，促进创新并加快 开发新的诊断、再生和其他治疗方法。通过吸引年轻人 我们将丰富血管生物学领域，并确保其未来的安全。

PROJECT SUMMARY Since its inception in 1980, the International Vascular Biology Meeting (IVBM) has been a time-honored and profoundly impactful biennial event. This meeting provides a unique opportunity for the global community to exchange and discuss new scientific discoveries, and to chart innovative and collaborative future scientific directions in vascular biology. The IVBM has also served to foster the next generation of scientists in vascular medicine. IVBM 2022 (October 13-17, 2022 in Oakland, CA) will cover a broad spectrum of vascular biology, prioritizing emerging areas of research. The vasculature impacts every organ system in development, aging, and disease and is critical to processes of regeneration. Blood vessel walls regulate multiple physiological functions, including vasomotor tone, leukocyte trafficking, innate and acquired immunity, permeability, stem cell differentiation, regeneration, and new blood formation. Abnormalities in any of these functions lead to disease. Beyond traditional vessel wall pathologies such as atherosclerosis and hypertension, the vasculature contributes to cancer, neurological disease, diabetes, hematological and immunological disorders, aging, and infectious processes, most recently COVID-19. Mounting evidence suggests that many COVID-19 symptoms are due to the virus attacking the vasculature. Advances in vascular biology have led to the development of many new therapies and preventive strategies with broad impact including those mitigating tumor growth and restoring vision. IVBM 2022 will provide a timely forum to exchange new knowledge in the rapidly expanding field of vascular biology, facilitate cross-disciplinary collaboration and critical interactions between seasoned investigators and trainees, and promote awareness of diverse vascular beds in health and disease. Our objective is to ignite novel areas of research between academia and industry, and from basic to translational research and clinical medicine, with the ultimate goal of improving human health. IVBM 2022 is being organized by the North American Vascular Biology Organization (NAVBO), an organization with a strong track record of promoting trainees and junior faculty. A significant number of oral presentations are reserved for junior scientists to promote their career growth. NAVBO is committed to diversity and equity within and beyond the vascular biology community; the IVBM organizers and speakers include women, junior faculty, underrepresented groups, and scientists from around the world. We selected the diverse city of Oakland, CA as the conference site. Our program facilitates cross-fertilization of scientific insights related to different vascular beds (brain, heart, lung, kidney, liver, and eye) and diverse disciplines (cell biology, genetics, imaging, bioengineering, mathematics, physics, systems biology, translational research, and drug discovery). By promoting such interactions, we will generate new basic knowledge of developmental and disease processes, catalyze innovation, and expedite development of new diagnostic, regenerative and other therapeutic approaches. By engaging young investigators and fostering diversity we will enrich the field of vascular biology and secure its future.